LKB1-KO/Kras-G12D-Luc
Strain Information
Validation Data
Fig1. The genotype of LKB1-KO/Kras-G12D-Luc cell was identified by PCR
WT: wild-type cells; H2O: negative water control; 100bp DNA marker from Transgen(BM311)
Fig2. Tumor growth curve in LKB1-KO/Kras-G12D-Luc subcutaneously transplanted tumor model (n=6)
Fig3. Body weight change in LKB1-KO/Kras-G12D-Luc subcutaneously transplanted tumor model (n=6)
Fig4. Signal increase curve of LKB1-KO/Kras-G12D-Luc cells were implanted orthotopically in the lung (n=6)
Fig5. Body weight change in orthotopically injected LKB1-KO/Kras-G12D-Luc model (n=6)
Fig6. Survival curve of LKB1-KO/Kras-G12D-Luc orthotopic model (n=6)
Fig7. Bioluminescence imaging of LKB1-KO/Kras-G12D-Luc subcutaneously transplanted tumor model at different timepoints
Fig8. Bioluminescence imaging of LKB1-KO/Kras-G12D-Luc orthotopic model (n=6)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
